BOLINGBROOK, Ill.--(BUSINESS WIRE)-- Ulta Beauty, Inc. (NASDAQ: ULTA), today announced that Christopher DelOrefice has been named as Ulta Beauty's next Chief Financial Officer. Mr. DelOrefice will begin his new role on December 5, 2025, and Chris Lialios will continue to serve as Interim Chief Financial Officer until such time.

Mr. DelOrefice is an experienced business leader who has led global, cross-functional teams at companies that have delivered superior financial performance. He joins Ulta Beauty from Becton Dickinson & Company, where he has served as Executive Vice President and Chief Financial Officer since September 2021. Prior to Becton Dickinson, Mr. DelOrefice spent more than 20 years with Johnson & Johnson, a multinational pharmaceutical, biotechnology, and medical technologies company, and held financial leadership roles of increasing responsibility including as Vice President, Investor Relations, Vice President Finance and CFO, North America Hospital Medical Devices, and Vice President Finance and CFO, North America Consumer. Earlier in his career, he held leadership positions in accounting, financial reporting, global audit, and supply chain finance at Astra Zeneca Pharmaceuticals, AET Films, Inc. and Ametek, Inc. Mr. DelOrefice is a Certified Public Accountant (inactive) and holds both a B.S. in Accounting and an M.B.A. from Villanova University. Mr. DelOrefice serves on the Board of Directors for ResMed and serves as the Chair of ResMed's audit committee.